Quantcast

Latest biopharmaceutical Stories

2014-06-19 23:13:54

Transparency Market Research includes new market research report "Biopharmaceutical Outsourcing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its huge collection of research reports. Browse the full report: http://www.transparencymarketresearch.com/biopharmaceutical-outsourcing-market.html Albany, NY (PRWEB) June 19, 2014 Biopharmaceutical market is very competitive and global players occupying majority of market share operate in same...

2014-06-18 12:32:44

--Data indicate ASM-024 DPI safe and generally well-tolerated in asthma-- QUEBEC CITY, Quebec, June 18, 2014 /PRNewswire/ -- Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of novel, proprietary compounds that target cholinergic receptors for the treatment of pulmonary diseases, today announced top-line results from a combined Phase 1 and 2a trial evaluating its lead compound, ASM-024, in moderate asthma patients. The data comes from Asmacure's recently...

2014-06-18 08:28:25

BASKING RIDGE, N.J., June 18, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the Phase 3 clinical development of Revolixys(TM) Kit (also known as REG1), its first-in-class, actively controllable injectable antithrombotic drug system, today announced the appointment of Drew Fromkin to the company's Board of Directors. Mr. Fromkin most recently served as President, Chief Executive Officer, of Clinical Data, Inc., prior to its...

2014-06-17 08:29:28

LA JOLLA, Calif., June 17, 2014 /PRNewswire/ -- Avidity NanoMedicines, a biopharmaceutical company pioneering development of the Antibody-siRNA Complex (ARC(TM)) as a new therapeutic class, announced today the issuance of two new U.S. patents. ARCs(TM) combine the potency and specificity of biologics with a nucleic acid-based payload, representing a breakthrough approach to the targeted delivery of nucleic acid-based medicines. The two new U.S. patents arose out of pioneering work...

2014-06-17 08:28:44

SEATTLE, June 17, 2014 /PRNewswire/ -- CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, have entered into a Master Services Agreement for process validation activities and clinical manufacturing of another of MacroGenics'...

2014-06-12 08:29:12

Company Must Remedy Noncompliance with Audit Committee Requirements as Set Forth in Listing Rule 5605 HERZLIYA, Israel, June 12, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, announced today that it received a letter from the Nasdaq Stock Market LLC ("Nasdaq") dated...

2014-06-12 08:28:46

SAN DIEGO, June 12, 2014 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced two poster presentations at the 19(th) Congress of the European Hematology Association (EHA), to be held June 12 through June 15, 2014, in Milan, Italy. Quizartinib (AC220) in Patients with FLT3-ITD(+) Relapsed or Refractory Acute Myeloid Leukemia: Final...

2014-06-12 08:28:27

Today most medicines are produced biotechnologically. A new cleaning method developed at ACIB combines five purification steps and leads to an extremely facilitated, more economical and ecological manufacturing process. GRAZ, Austria, June 12, 2014 /PRNewswire/ -- Seven of the ten best-selling drugs in 2012 were biopharmaceuticals; biotechnology in pharmaceutical production is still growing. A severe problem is the cleaning of products; up to 80% of the total production costs are...

2014-06-10 08:29:48

QUÉBEC CITY, June 10, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced the roll-out of a global resources optimization program as the Company pursues its strategy of transitioning into a commercially operating specialty biopharmaceutical company. Initiated earlier this year, the program's goal is to streamline R&D activities and increase commercial operations and flexibility. With the implementation of the global resources...

2014-06-09 16:25:42

JUPITER, Fla., June 9, 2014 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced that Dyadic's Chief Operating Officer Danai Brooks will present at the 2014 Global Biotechnology Conference on Wednesday, June 18, 2014 at 4:10 p.m. ET at the John B. Hynes...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related